Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Therapeuticsmd Inc (TXMD)

Therapeuticsmd Inc (TXMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 22,141
  • Shares Outstanding, K 11,532
  • Annual Sales, $ 1,300 K
  • Annual Income, $ -10,280 K
  • 60-Month Beta 1.04
  • Price/Sales 16.39
  • Price/Cash Flow N/A
  • Price/Book 0.74
Trade TXMD with:

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 40.64%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 803.91% on 03/18/24
  • IV Low 0.00% on 06/21/24
  • Put/Call Vol Ratio 0.25
  • Today's Volume 5
  • Volume Avg (30-Day) 5
  • Put/Call OI Ratio 0.48
  • Today's Open Interest 426
  • Open Int (30-Day) 414

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.8400 +4.35%
on 06/21/24
2.2200 -13.51%
on 06/03/24
-0.1700 (-8.13%)
since 05/21/24
3-Month
1.8400 +4.35%
on 06/21/24
2.3935 -19.78%
on 03/22/24
-0.3800 (-16.52%)
since 03/21/24
52-Week
1.8400 +4.35%
on 06/21/24
4.3500 -55.86%
on 08/04/23
-2.0200 (-51.27%)
since 06/21/23

Most Recent Stories

More News
TherapeuticsMD: Q1 Earnings Snapshot

TherapeuticsMD: Q1 Earnings Snapshot

TXMD : 1.9200 (+3.78%)
TherapeuticsMD: Q3 Earnings Snapshot

TherapeuticsMD: Q3 Earnings Snapshot

TXMD : 1.9200 (+3.78%)
TherapeuticsMD: Q2 Earnings Snapshot

TherapeuticsMD: Q2 Earnings Snapshot

TXMD : 1.9200 (+3.78%)
TherapeuticsMD: Q1 Earnings Snapshot

TherapeuticsMD: Q1 Earnings Snapshot

TXMD : 1.9200 (+3.78%)
TherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model Transition

TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the full year ended December...

TXMD : 1.9200 (+3.78%)
TherapeuticsMD Completes Transaction to License Its Products to Mayne Pharma

TherapeuticsMD, Inc. (NASDAQ: TXMD) (“TherapeuticsMD,” “TXMD” or the “Company”), an innovative, leading women’s healthcare company, today announced that it has completed its previously announced...

TXMD : 1.9200 (+3.78%)
Pre-Market Brief: Stocks Mixed As Labor Market Strength Weigh On Sentiment

December S&P 500 futures (ESZ22) are trending down -0.30% this morning after three major US benchmark indices closed mixed on Friday as the November payrolls report fueled expectations the Federal Reserve...

ESZ22 : 3,871.47s (-0.66%)
TXMD : 1.9200 (+3.78%)
IOVA : 8.01 (+0.50%)
IMPP : 3.72 (+5.38%)
CLVS : 0.0812 (-5.58%)
UTHR : 316.04 (+2.28%)
SBUX : 79.91 (+0.24%)
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma

TherapeuticsMD, Inc. (NASDAQ: TXMD) (“TherapeuticsMD,” “TXMD” or the “Company”), an innovative, leading women’s healthcare company, today announced that it has entered into definitive agreements...

TXMD : 1.9200 (+3.78%)
TherapeuticsMD Announces Third Quarter 2022 Financial Results

TherapeuticsMD, Inc. (“TXMD” or the “Company”) (NASDAQ: TXMD), an innovative, leading women’s healthcare company, today reported financial results for the third quarter ended September 30, 2022....

TXMD : 1.9200 (+3.78%)
TherapeuticsMD Announces Additional $7 Million Private Placement

TherapeuticsMD, Inc. (NASDAQ: TXMD), (“TherapeuticsMD” or the “Company”) an innovative, leading women’s healthcare company, announced today that it received an additional $7 million private investment...

TXMD : 1.9200 (+3.78%)

Business Summary

TherapeuticsMD, Inc. is a specialty pharmaceutical company focused on creating branded prescription, generic prescription and over-the-counter products targeted exclusively for women. It is developing three advanced hormone replacement products designed to alleviate the symptoms of and reduce the health...

See More

Key Turning Points

3rd Resistance Point 2.0350
2nd Resistance Point 1.9800
1st Resistance Point 1.9500
Last Price 1.9200
1st Support Level 1.8650
2nd Support Level 1.8100
3rd Support Level 1.7800

See More

52-Week High 4.3500
Fibonacci 61.8% 3.3912
Fibonacci 50% 3.0950
Fibonacci 38.2% 2.7988
Last Price 1.9200
52-Week Low 1.8400

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar